CA
RCEL icon

Clearstead Advisors’s Avita Medical RCEL Stock Holding History

Clearstead Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Buy
+3
New +$13 ﹤0.01% 3611
2025
Q4 		– Sell
-66
Closed -$338 – 3160
2025
Q3 		$338 Buy
+66
New +$344 ﹤0.01% 2788

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Clearstead Advisors's RCEL Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Avita Medical (RCEL) in Q2 2026: 3 shares worth $13. The stake represents ﹤0.01% of the portfolio and ranks #3611 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in RCEL as recently as Q3 2025.

Clearstead Advisors first reported a position in RCEL in Q3 2025 and has held it in 2 quarters since. The position peaked at $338 in Q3 2025. 24 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Clearstead Advisors held 3 shares of Avita Medical worth $13 as of Q2 2026.
  • Avita Medical was a new Clearstead Advisors position in Q2 2026.
  • Avita Medical made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3611 holding.
  • Clearstead Advisors first reported a position in Avita Medical in Q3 2025 and has held it in 2 quarters since.
  • Clearstead Advisors's Avita Medical position peaked at $338 in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.